Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Vansteenkiste, Johan F Cho, Byoung Chul Vanakesa, Tonu De Pas, Tommaso Zielinski, Marcin Kim, Moon Soo Jassem, Jacek Yoshimura, Masahiro Dahabreh, Jubrail Nakayama, Haruhiku Havel, Libor Kondo, Haruhiko Mitsudomi, Tetsuya Zarogoulidis, Konstantinos Gladkov, Oleg A Udud, Katalin Tada, Hirohito Hoffman, Hans Bugge, Anders Taylor, Paul Gonzalez, Emilio Esteban Liao, Mei Lin He, Jianxing Pujol, Jean-Louis Louahed, Jamila Debois, Muriel Brichard, Vincent Debruyne, Channa Therasse, Patrick Altorki, Nasser